Keyphrases
Cancer Patients
11%
Cancer Survivors
11%
Chemotherapy
100%
Chemotherapy Toxicity
11%
Chemotherapy-induced Peripheral Neuropathy
100%
Cytostatic
11%
Dose-limiting Toxicity
11%
Functional Assessment of Cancer Therapy
11%
Gynecologic Oncology Group
11%
Housekeeping
11%
Improved Survival
11%
Lower Extremity
11%
Medical Center
11%
Netherlands
11%
Neurotoxicity
77%
Numbness
11%
Oncology
11%
Overall Quality of Life
11%
Oxaliplatin
22%
Oxaliplatin Chemotherapy
22%
Patient Well-being
22%
Quality of Life
44%
Quality of Life Impact
100%
Sample Size Selection
11%
Selection Bias
11%
Small Sample Size
11%
Taxane Chemotherapy
22%
Taxanes
22%
Tingling
11%
Upper Extremity
11%
Medicine and Dentistry
Cancer Therapy
10%
Chemotherapy
100%
Chemotherapy-Induced Peripheral Neuropathy
100%
Cytostatic Agent
10%
Functional Assessment
10%
Gynecological Oncology
10%
Malignant Neoplasm
30%
Neurotoxicity
80%
Oncology
10%
Oxaliplatin
40%
Paresthesia
10%
Quality of Life
100%
Selection Bias
10%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Chemotherapy-Induced Peripheral Neuropathy
100%
Cytostatic Agent
11%
Malignant Neoplasm
44%
Neurotoxicity
88%
Oxaliplatin
44%
Paresthesia
11%
Taxane
44%
Nursing and Health Professions
Cancer Therapy
10%
Chemotherapy-Induced Peripheral Neuropathy
100%
Cytostatic Agent
10%
Functional Assessment
10%
Malignant Neoplasm
30%
Neurotoxicity
80%
Oxaliplatin
40%
Paresthesia
10%
Quality of Life
100%
Sample Size
10%